When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

If you are considering a natural over the counter Mounjaro alternative for 2025 - we have the top 3 options for you. SAN FRANCISCO, CA / ACCESSWIRE / December 18, 2024 / If you've been following ...

Key Takeaways, With Data for Maryland FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

The European Union's drug regulator said it would review a potential link between Novo Nordisk's blockbuster diabetes drug, Ozempic, and a rare eye condition that causes vision loss after recent ...

The company behind KitKat has launched a protein drink that it claims suppresses appetite in the same way as popular ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

The European Union's drug regulator said it would review two scientific studies that link Novo Nordisk's blockbuster diabetes drug Ozempic to a rare eye condition.

Statements by Robert F. Kennedy Jr. and Elon Musk tap into a dispute over whether lifestyle changes or drugs are a better way to treat obesity.

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...